These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 2501384)
1. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein. Pan AA; McMahon-Pratt D J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants. Pan AA; McMahon-Pratt D J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920 [TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: characterization of an intracellular epimastigote-like form. Almeida-de-Faria M; Freymüller E; Colli W; Alves MJ Exp Parasitol; 1999 Aug; 92(4):263-74. PubMed ID: 10425154 [TBL] [Abstract][Full Text] [Related]
4. Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi. Kirchhoff LV; Hieny S; Shiver GM; Snary D; Sher A J Immunol; 1984 Nov; 133(5):2731-5. PubMed ID: 6207242 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi. Imaz MS; Esteva M; Velázquez E; Ruiz AM; Segura EL; Marcipar AJ Rev Latinoam Microbiol; 1997; 39(1-2):33-46. PubMed ID: 10932713 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants. Jaffe CL; McMahon-Pratt D J Immunol; 1983 Oct; 131(4):1987-93. PubMed ID: 6194223 [TBL] [Abstract][Full Text] [Related]
7. Proteins anchored via glycosylphosphatidylinositol and solubilizing phospholipases in Trypanosoma cruzi. de Almeida ML; Heise N Biol Res; 1993; 26(1-2):285-312. PubMed ID: 7670541 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein. Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244 [TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease. Gruber A; Zingales B Exp Parasitol; 1993 Feb; 76(1):1-12. PubMed ID: 8467895 [TBL] [Abstract][Full Text] [Related]
10. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp]. Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482 [TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi: characterization and isolation of a 57/51,000 m.w. surface glycoprotein (GP57/51) expressed by epimastigotes and bloodstream trypomastigotes. Scharfstein J; Schechter M; Senna M; Peralta JM; Mendonça-Previato L; Miles MA J Immunol; 1986 Aug; 137(4):1336-41. PubMed ID: 3090146 [TBL] [Abstract][Full Text] [Related]
12. [Partial purification and use of Trypanosoma cruzi glycosidic fractions for Chagas disease diagnosis]. De Lima Rivero AR; Farías Tamoy MN; Tortolero Leal E; Navarro Aguilera MC; Contreras Alvarez VT Acta Cient Venez; 2001; 52(4):235-47. PubMed ID: 11915441 [TBL] [Abstract][Full Text] [Related]
13. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression. Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533 [TBL] [Abstract][Full Text] [Related]
14. Immunological characterization of antigens released by Trypanosoma cruzi-infected cells. Grijalva MJ; Goodrum KJ; Rowland EC J Parasitol; 1999 Aug; 85(4):663-71. PubMed ID: 10461946 [TBL] [Abstract][Full Text] [Related]
15. Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease. Berrizbeitia M; Ndao M; Bubis J; Gottschalk M; Aché A; Lacouture S; Medina M; Ward BJ J Clin Microbiol; 2006 Feb; 44(2):291-6. PubMed ID: 16455872 [TBL] [Abstract][Full Text] [Related]
16. Distribution of Trypanosoma cruzi stage-specific epitopes in cardiac muscle of Calomys callosus, BALB/c mice, and cultured cells infected with different infective forms. Taniwaki NN; da Silva CV; da Silva S; Mortara RA Acta Trop; 2007 Jul; 103(1):14-25. PubMed ID: 17582377 [TBL] [Abstract][Full Text] [Related]
17. [Molecular and immunologic bases for the development of a vaccine against Chagas disease]. Segura EL; Cardoni RL; Búa J; Rottenberg ME; Bontempi EJ; Esteva MI; Carlomagno MA; De Titto EH; Ruiz AM Medicina (B Aires); 1989; 49(3):203-9. PubMed ID: 2518642 [TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi tubulin eliminated in the urine of the infected host. Bertot GM; Corral RS; Fresno M; Rodríguez C; Katzin AM; Grinstein S J Parasitol; 1998 Jun; 84(3):608-14. PubMed ID: 9645865 [TBL] [Abstract][Full Text] [Related]
19. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis. Jaffe CL; Bennett E; Grimaldi G; McMahon-Pratt D J Immunol; 1984 Jul; 133(1):440-7. PubMed ID: 6373932 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against Trypanosoma cruzi neuraminidase reveal enzyme polymorphism, recognize a subset of trypomastigotes, and enhance infection in vitro. Prioli RP; Mejia JS; Pereira ME J Immunol; 1990 Jun; 144(11):4384-91. PubMed ID: 2111345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]